Department of Medical and Molecular Genetics, Indiana University School of Medicine.
Riley Heart Center, Riley Hospital for Children, Indianapolis, Indiana, USA.
Curr Opin Pediatr. 2020 Dec;32(6):730-738. doi: 10.1097/MOP.0000000000000949.
This article reviews the current understanding and limitations in knowledge of the effect genetics and genetic diagnoses have on perioperative and postoperative surgical outcomes in patients with congenital heart disease (CHD).
Presence of a known genetic diagnosis seems to effect multiple significant outcome metrics in CHD surgery including length of stay, need for extracorporeal membrane oxygenation, mortality, bleeding, and heart failure. Data regarding the effects of genetics in CHD is complicated by lack of standard genetic assessment resulting in inaccurate risk stratification of patients when analyzing data. Only 30% of variation in CHD surgical outcomes are explained by currently measured variables, with 2.5% being attributed to diagnosed genetic disorders, it is thought a significant amount of the remaining outcome variation is because of unmeasured genetic factors.
Genetic diagnoses clearly have a significant effect on surgical outcomes in patients with CHD. Our current understanding is limited by lack of consistent genetic evaluation and assessment as well as evolving knowledge and discovery regarding the genetics of CHD. Standardizing genetic assessment of patients with CHD will allow for the best risk stratification and ultimate understanding of these effects.
本文回顾了目前对于遗传学和基因诊断对先天性心脏病(CHD)患者围手术期和术后手术结果的影响的认识和局限性。
已知的基因诊断似乎对 CHD 手术中的多个重要结果指标有影响,包括住院时间、体外膜氧合的需要、死亡率、出血和心力衰竭。由于缺乏标准的基因评估,导致在分析数据时对患者进行风险分层不准确,因此关于遗传学在 CHD 中的作用的数据很复杂。目前测量的变量仅能解释 CHD 手术结果的 30%,其中 2.5%归因于已诊断的遗传疾病,据认为,剩余的大部分结果差异是由于未测量的遗传因素所致。
基因诊断对 CHD 患者的手术结果有明显影响。我们目前的认识受到缺乏一致的基因评估和评估以及不断发展的关于 CHD 遗传学的知识和发现的限制。对 CHD 患者进行标准化的基因评估将有助于进行最佳的风险分层,并最终了解这些影响。